-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Korro Bio, Lowers Price Target to $90

Benzinga·05/13/2025 17:50:37
Listen to the news
Oppenheimer analyst Andreas Argyrides maintains Korro Bio (NASDAQ:KRRO) with a Outperform and lowers the price target from $155 to $90.